EU-STANDS4PM
EU-STANDS4PM - European standards for data integration and data-driven in silico models for personalized medicine
The DIN Standards Committee for Medicine (NAMed) has been a partner in the three-year EU-STANDS4PM research project. The project is funded by the EU Framework Programme for Research and Innovation Horizon 2020 and brings together a consortium of 16 leading scientific institutions, European organisations and companies led by the Project Management Juelich.
EU-STANDS4PM is an open network and seeks input from all relevant stakeholders that have an interest in advancing predictive in silico methodologies in personalised medicine through broadly applicable standards for data integration and harmonisation. The goal is to sustain the competitiveness of the European Research Area and to ensure a leading role for the European personalised medicine community of stakeholders in the transition from current reactive medical practice to a data-driven and predictive medicine of the future.
The EU-STANDS4PM consortium has the overarching aim to bundle transnational standardization guidelines for in silico methodologies in transnational and clinical research to:
- harmonise health and disease data integration strategies to further strengthen data-driven in silico modelling approaches for personalised medicine in Europe;
- facilitate a sustained use of Life Science data in clinical and health research;
- advise regulatory authorities on a broad adaptation of harmonised health data and standards in research, and industry;
- enable FAIR principles (Findable, Accessible, Interoperable and Reproducible) (Wilkinson et al., 2016) as well as legal and ethical requirements for the above tasks and
- accelerate growth of the European data-driven economy.
The following film (duration: 4:13 min) gives you a short overview of the project and its goals: LINK.
Project duration
January 2019 until December 2021
Project partners
- Forschungszentrum Jülich GmbH (DE)
- Bayer Aktiengesellschaft (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- Erasmus Universitair Medisch Centrum Rotterdam (NL)
- European Molecular Biology Laboratory (DE)
- HITS GGmbH (DE)
- Federal Agency for Medicines and Health Products (BE)
- Deutsches Institut für Normung e. V. (DE)
- Karolinska Institutet (SE)
- Qiagen GmbH (DE)
- University College London (UK)
- Kobenhavns Universitet (UCEPH) (DK)
- The Chancellor, Mastes and Scholars of the University of Oxford (UK)
- Universita Degli Studi di Parma (IT)
- Univerität Rostock (DE)
- Vilniaus Universitetas (LT)
This project is funded by the European Commission under the Horizon 2020 Programme under grant agreement no. 825843.
More information: https://www.eu-stands4pm.eu/